法瑞西单抗
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
选择数量
- +
基本信息
中文名称法瑞西单抗
英文名称 Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
CAS号1607793-29-2
储存条件store at -20°C
安全信息
产品详情

Faricimab is a pioneering humanized bispecific antibody that targets both VEGF-A and Ang-2, offering a dual inhibition approach for retinal diseases like DME and nAMD. By inhibiting VEGF-A, it reduces endothelial cell proliferation and vascular permeability, while blocking Ang-2 is believed to enhance vascular stability and counteract VEGF-A effects. Faricimab has demonstrated a significant reduction in annual injections compared to other anti-VEGF treatments, with a comparable efficacy and safety profile, positioning it as a valuable treatment option for patients with retinal diseases.


相关产品
抱歉,暂时没有相关产品
浏览记录
普拉替尼
莫妥珠单抗
法瑞西单抗
辣椒素酯
(5-(甲基磺酰基)-2-(((R)-1,1,1--三氟丙-2-基)氧基)苯基)((1R,5R)-1-(5-(三氟甲基)异恶唑-3-基)-3-氮杂双环[3.1.0]己烷-3-基)甲酮
(S)-1-BOC-吡咯烷-3-甲酸 | 吡咯烷-1,3-二羧酸-1-叔丁酯
鲁索替尼 | 鲁索利替尼 | 芦可替尼
鲁玛卡托
伐诺司林二盐酸盐
褪黑素(N-乙酰基-5-甲氧基色胺)